Dividend compounder review

INCY

Incyte Corporation · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score62.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 25.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 8.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 12.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$1.3B
Free Cash Flow$1.3B
FCF Covers DividendUnknown
Debt / Equity0.70
P/E15.3
Revenue Growth 5Y14.0%
Net Margin26.7%
ROE30.8%
Price vs Trend9.1%
3Y Return73.8%
5Y Return25.0%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

INCY dividend review warning Warning · Warning

No usable dividend history found.